Faculty Profiles

Home|Faculty|Faculty Directory|Faculty Profiles

Biography
Shahrokh (Seve) Falati’s area of legal expertise includes intellectual property law, patent law, trademark and unfair competition law, and the interdisciplinary legal fields governing legal representation of entrepreneurs and innovators (a.k.a. entrepreneurship law). Prior to joining the faculty at Albany Law School, for over a decade, Professor Falati worked in private practice at two large prominent law firms in New York (Jones Day and HRFM) and focused his practice on representing clients on intellectual property law and related legal matters. He has represented university researchers (including a Nobel Laureate in Medicine), start-up companies developing new technologies, and larger established corporations on their intellectual property law and related legal needs. He still maintains a small personal private legal practice, aiming to use this as leverage to connect capable students to industry. Professor Falati teaches Intro to Intellectual Property Law; Patent Law; Trademark & Unfair Competition Law; and Entrepreneurship Law in Emerging Technologies; and he is the Director of Programs for Intellectual Property, Technology Transfer & Entrepreneurship. He is admitted to practice law in New York and Massachusetts, before the United States District Court for the District of Massachusetts, and as a registered patent attorney before the United States Patent and Trademark Office.
Seve emigrated from the Middle East to Europe as a child and attended University in Scotland and England, graduating with a B.Sc. with Honors and a Ph.D., both in Pharmacology. In 1999, he was fortunate enough to then be offered a fellowship in Boston. He moved from London to Boston and completed a three year fellowship at Harvard Medical School/Beth Israel Deaconess Medical Center as Fellow in Medicine. Seve's Ph.D. and Postdoctoral Fellowship, both in the field of Blood and Cardiovascular Disease, produced several publications. Four of these publications were high-impact first author publications (in Nature Medicine, Journal of Experimental Medicine, and two in Blood) which have since been cited more than 1500 times by subsequent scientific papers. One of these four papers addressed a difficult long-standing scientific question related to blood and by necessity was a major collaboration between more than a dozen scientists in four prominent institutions in the U.S., U.K, and Canada. Seve led the international collaborative project and presented the results on behalf of the multinational team at a large international conference in Sydney, Australia.
Read more:
• Faculty Spotlight: Professor Falati, Students to Help Entrepreneurs Develop High-Impact Ideas
• New International Opportunity for Albany Law Students: ‘Innovation & Technology Law Summer School’ in Italy | Poster/Agenda [PDF]

Books

Publications

Platelet PECAM-1 Inhibits Thrombus Formation in Vivo, 107 Blood 535 (2006) (with Sonali Patil, Peter L. Gross, Michelle Stapleton, Glenn Merrill-Skoloff, Natasha E. Barrett, Katherine L. Pixton, Harmut Weiler, Brian Cooley, Debra K. Newman, Peter J. Newman, Barbara C. Furie, Bruce Furie, and Jonathan M. Gibbins)Link to publication
In Vivo Models of Platelet Function and Thrombosis: Study of Real-Time Thrombus Formation, chapter in METHODS IN MOLECULAR BIOLOGY: PLATELETS AND MEGAKARYOCYTES (Humana Press 2004) (Jonathan M. Gibbins and Martyn P. Mahaut-Smith, eds.) (with Peter L. Gross, Glenn Merrill-Skoloff, Derek Sim, Robert Flaumenhaft, Alessandro Celi, Barbara C. Furie, and Bruce Furie) Link to publication
GPib Potentiates GPVI-Induced Responses in Human Platelets, 15 Platelets 207 (2004) (with Julie Baker, Rebecca K. L. Griggs, and Alastair W. Poole)Link to publication
Antibody Cross-Linking of Human Platelet P-Selectin Induces Calcium Entry By a Mechanism Dependent upon Fcγ Receptor IIA, 92 Thrombosis Haemostasis 598 (2004) (with Jean G. Sathish, Kevin Croce, Colin Crump, Barbara C. Furie, Bruce Furie, and Alastair W. Poole)Link to publication
Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin, 197 Journal of Experimental Medicine 1585 (2003) (with Qingde Liu, Peter Gross, Glenn Merrill-Skoloff, Janet Chou, Erik Vandendries, Alessandro Celi, Kevin Croce, Barbara C. Furie, and Bruce Furie)Link to publication
Thrombi in P-Selectin Null, PSGL-1 Null And Fibrinogen Null Mice Undergo Increased Thromboemolization, 102 Blood 10A (2003) (with D. S. Sim, E. Rosen, F.J. Castellino, B. Furie, R. Flaumenhaft, and B. C. Furie)
Thrombus Formation: Direct Real‐Time Observation and Digital Analysis of Thrombus Assembly in a Living Mouse By Confocal and Widefield Intravital Microscopy, 1 Journal of Thrombosis and Haemostasis 60 (2003) (with A. Celi, G. Merrill‐Skoloff, P. Gross, D. S. Sim, R. Flaumenhaft, B. C. Furie, and B. Furie)Link to publication
Real-Time in Vivo Imaging of Platelets, Tissue Factor and Fibrin During Arterial Thrombus Formation in the Mouse, 8 Nature Medicine 1175 (2002) (with Peter Gross, Glenn Merrill-Skoloff, Barbara C. Furie, and Bruce Furie)Link to publication
In Vivo Real Time Imaging of Arterial Thrombus Formation Reveals P-Selectin-And PSGL-1-Mediated Tissue Factor Accumulation as a Mechanism for Fibrin Clot Generation, 98 Blood 823A (2001) (with P. Gross, G. Merrill-Skoloff, K. Croce, B. C. Furie, and B. Furie)
Activation Of Glycoprotein GP Ib-V-IX, a Receptor for Von Willebrand Factor, Initiates a Cascade of Tyrosine Phosphorylation Signalling Events in Human Platelets, 27 Biochemical Society Transactions A120 (1999)
Glycoprotein Ib-V-IX, a Receptor for von Willebrand Factor, Couples Physically and Functionally to the Fc Receptor γ-Chain, Fyn, and Lyn to Activate Human Platelets, 94 Blood 1648 (1999) (with Christine E. Edmead and Alastair W. Poole) Link to publication
Glycoprotein GP Ib-V-IX Couples to the Fc Receptor Gamma-Chain, Fyn And Lyn, to Activate Human Platelets, Thrombosis & Haemostasis, 208 (1999) (with Christine E. Edmead and Alastair W. Poole)
Von Willebrand Factor Induces Tyrosine Phosphorylation of the Tyrosine Kinase Syk, P95vav and Phospholipase C Gamma 2 in Human Platelets, 122 British Journal of Pharmacology 103 (1997) (with T. Vink, J. Sixma, and A. W. Poole)

Forthcoming Publications

Selected Achievements

Professor Shahrokh Falati presented "Promoting Innovation: U.S Laws Versus European Laws, and Their Effect on New Technology Development" and "Looking Ahead: How Intellectual Property Laws Will Likely Handle The Forthcoming Era of 3D Printing" at the Innovation and Technology Law Summer School at Università di Padova Law School in Padova, Italy, June 18-22, 2018.
Professors Seve Falati, Mary Lynch, and Nancy Maurer delivered a collaborative presentation about assessment at the national conference Externships 9: Coming of Age, March 9-11, 2018 at the University of Georgia School of Law in Athens, Ga.
Professor Shahrokh Falati presented a talk at the American Bar Association Workshop on Science and Technology Law, titled "Commercializing Ideas: Key Takeaways For Entrepreneurs."
Professor Shahrokh Falati presented "Commercializing Ideas: What Science and Engineering University Research Personnel Need to Know" at The Road from Nanomedicine to Precision Medicine: 15th Annual International Conference at the Albany College of Pharmacy and Health Sciences on September 25, 2017.
Professor Shahrokh Falati was elected to be the 2017 President of the Eastern NY Intellectual Property Law Association.
Professor Seve Falati was selected as Committee Chair for organizing the Capital Region Biotechnology Innovation Day, working with Dr. Steve Festin and the Center for Economic Growth to put together a program at Rensselaer Polytechnic Institute comprising 130 participants from industry and academia. He also moderated the panel “Opportunities for Entrepreneurs in New York State” during the one-day conference in September 2016.

In the News

Professor Seve Falati was featured in the Albany Business Review's "People on the Move" on September 7, 2016.

Shahrokh Falati

Cour​se​s​​​